Results of phase 1 clinical trial evaluating efficacy of 3rd party cord blood regulatory T cells for prevention of graft versus host disease von Kellner, Joshua, Yvon, Eric, Khoury, Joseph, Nguyen, Tuongvan, Ramos, Jennifer, Olson, Amanda Leigh, Nieto, Yago, Ciurea, Stefan O., Nierkens, Stefan, Delemarre, Elena, Boelens, Jaap Jan, Champlin, Richard E., Andersson, Borje, Parmar, Simrit

Volltext